Curis Inc (NASDAQ:CRIS)
| 0.4506 Delayed Data As of Sep 22 |  -0.0024 / -0.53%Today’s Change | 0.43 Today|||52-Week Range 1.00 | -18.07% Year-to-Date |
Latest CRIS News | Press Releases
| Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock? Sep 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.45 |
| Today’s open | 0.46 |
| Day’s range | 0.45 - 0.46 |
| Volume | 240 |
| Average volume (3 months) | 299,149 |
| Market cap | $53.4M |
Data as of 3:58pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -22.29% |
| Earnings growth (this year) | +24.59% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -4.57% |
| P/E ratio | NM |
| Price/Sales | 5.05 |
| Price/Book | 0.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DYAIDyadic International... | 0.00 | 0.00% |
| VTGNVistagen Therapeutic... | +0.11 | +2.14% |
| AGLEAeglea Bio Therapeut... | +0.43 | +3.68% |
| OTLKOutlook Therapeutics... | +0.00 | +0.57% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 7, 2023 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $10.2M |
| Annual profit (last year) | -$56.7M |
| Net profit margin | -557.69% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
